The "Chimeric Antigen Receptor Macrophage (CAR-M) Immunotherapy - Pipeline Insight, 2025" drug pipelines has been added to ResearchAndMarkets.com's offering. This report outlays comprehensive insights ...

A new study led by researchers at Hospital for Special Surgery (HSS) suggests that currently available therapies may help ...

An international research team led by Professor Kiavash Movahedi from the Brussels Center for Immunology at the Vrije ...

A new study led by researchers at the Hospital for Special Surgery (HSS) suggests that currently available therapies may help ...

Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune ...

A recent study reveals that dimethyl fumarate (DMF), a compound already approved for other inflammatory diseases, can prevent ...

Following this standard treatment regimen, the rodents develop recurrent tumors, establishing what is referred to as an ...

Macrophages salvage nutrients from the bacteria they phagocytose to regulate inflammatory responses, revealing ...

In order to address the challenge of sepsis treatment through immune metabolic modulation, the research team led by Prof.

Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.

State Key Laboratory of Genetic Engineering, Department of Pharmaceutical Sciences, School of Life Sciences, Fudan University, Shanghai 200438, China MOE Engineering Research Center of Gene Technology ...